screenmytrade

REPL

Replimune Group, Inc.
Health Care
$15.19 0.05 (0.33%) Thu End-of-day close · Aug 13, 2026
7/10of the Ten Checks passing1 since Wednesday’s closeSame Ten Checks for every stock — a measurement, not a ranking or a call to act. How the Ten Checks work →
New to the Ten Checks? Learn to read them
Can you read a chart the way the Ten Checks do? Try today’s Daily Read

When REPL passed all Ten ChecksReplimune Group, Inc.

history · not a forecast

Over the past 10 years, REPL has passed all Ten Checks on 7 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.

Typical peak+10.2% the median high of all 7
Typical dip-10.0% the median low along the way

The strongest of them rose +39.6% in Nov 2022, peaked day 13.

Most recentpeakdip
  • Dec 2025-1.3% -30.5%
  • Jun 2023-1.8% -17.6%
  • Jan 2023+10.2% -3.4%

Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.

6-month history — checks vs. price

Price on the left axis; checks passing (0–10) on the right.

Close ($)Checks (0–10)
Aug 13, 20267/10 checks$15.19closelatest · hover the chart to scan
Checks passing over the last 126 sessions count only · not price
0510Feb 12Aug 13

Common questions about REPL’s checks

How many technical checks does REPL pass right now?

As of the Aug 13, 2026 close, REPL passes 7 of 10 fixed technical checks — the checks not passing: pulled back to support, no recent earnings miss, stop distance within range.

Why does REPL fail the "stop distance within range" check?

A stop at $11.41 is 24.9% below REPL's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.

Factual measurements from the latest scan — not investment advice.